Get started
Author

Burçak Yılmaz

Observed names: B Yilmaz, B. Yilmaz, Burcak Erkol Yilmaz, Burcak Erkol Yılmaz, Burcak Yilmaz, Burcak Yılmaz, Burçak E. Yilmaz, Burçak Erkol Yilmaz, Burçak Yilmaz
Institution: Biruni University
Observed institutions: Oregon Health & Science University, İstanbul Eğitim ve Araştırma Hastanesi, Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, Biruni University, Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi, Oregon Health and Science University Hospital, Şişli Etfal Eğitim ve Araştırma Hastanesi, İstanbul Başakşehir Çam ve Sakura Şehir Hastanesi
ORCID: 0000-0002-6979-0990
Observed ORCID: 0000-0002-6979-0990
OpenAlex ID: A5044367089
Comparison of preoperative locoregional Ga‐68 PSMA‐11 PET‐CT and mp‐MRI results with postoperative histopathology of prostate cancer
2019 · Burcak Yilmaz, Rustu Turkay, et al. · The Prostate · 52
Effect of External Cooling on 177Lu-PSMA Uptake by the Parotid Glands
2019 · Burcak Yilmaz, Serap Nisli, et al. · Journal of Nuclear Medicine · 51
PDF
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
2013 · Bulent Cetin, Mustafa Benekli, et al. · Journal of Chemotherapy · 36
Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?
2010 · Ahmet Bilici, Bala B.O. Ustaalioglu, et al. · Oncology Research and Treatment · 24
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients
2022 · Burçak Yılmaz, Selçuk Şahin, et al. · Annals of Nuclear Medicine · 22
Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses
2022 · Ayşegül Aksu, Özge Vural Topuz, et al. · Annals of Nuclear Medicine · 20
Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience
2012 · Bulent Cetin, Mustafa Benekli, et al. · Onkologie · 20
PDF
Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast
2010 · Mesut Seker, Ahmet Bilici, et al. · Archives of Gynecology and Obstetrics · 17
Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience
2010 · U. Kefeli, S. Kaya, et al. · Medical Oncology · 15
Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer
2009 · Ahmet Bilici, Mesut Seker, et al. · Medical Oncology · 15
The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer
2018 · Burcak Yilmaz, Sedef Dağ, et al. · Nuclear Medicine Communications · 12
Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
2018 · Zedef Dag, Burcak Yilmaz, et al. · Brachytherapy · 12
The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer
2012 · Ahmet Bilici, Bala Basak Oven Ustaalioglu, et al. · Tumor Biology · 12
Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer
2012 · Bala Basak Oven Ustaalioglu, Ahmet Bilici, et al. · Clinical & Translational Oncology · 12
Bilateral Conjunctival MALT Lymphoma Mimicking Chronic Conjunctivitis
2010 · Mesut Seker, Burak Ozdemir, et al. · Onkologie · 12
Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies
2024 · Nadine Mallak, Burcak Yilmaz, et al. · Current Problems in Cancer · 9
Surgical Approach to Anorectal Melanoma with PET-CT Staging: A Case Report
2017 · Nilufer Bulut, Sevinc Dagıstanlı, et al. · The Surgery Journal · 9
PDF
False-Positive 68Ga-DOTATATE PET/CT in Active Chronic Prostatitis
2019 · Burcak Yilmaz, Hilal Serap Arslan, et al. · Clinical Nuclear Medicine · 8
Tracheitis Diagnosed With 68Ga-PSMA PET/CT in a Patient With COVID-19
2022 · Ayşegül Aksu, Kübra Bozkurt, et al. · Clinical Nuclear Medicine · 7
The ability of pre-treatment F-18 FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival
2019 · Burcak Yilmaz, Sedef Dağ, et al. · Nuclear Medicine Communications · 7
The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma
2010 · Bala Basak Oven Ustaalioglu, Mesut Seker, et al. · Medical Oncology · 7
Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule
2024 · Cameron Chalker, Burçak Yilmaz, et al. · npj Precision Oncology · 2
Genetic analysis of metastatic castration resistant prostate cancer patients treated with Lu-177 PSMA radioligand therapy.
2024 · Burcak Yilmaz, Cameron Chalker, et al. · Journal of Clinical Oncology · 2
PDF
Diagnostic Accuracy of Preoperative Metabolic 18F-FDG PET/CT Parameters for Patients with Endometrial Cancer Treated with Postoperative Radiation Therapy
2021 · Sedef Dağ, Ayşe Kutluhan Doğan, et al. · Cam and Sakura Medical Journal · 2
PDF
Misleading 18 FDG-PET/CT finding caused by chronic HIV infection in a patient with gastric carcinoma: a case report
2017 · Nilufer Bulut, Burcak Yılmaz · International Journal of STD & AIDS · 2
Works count: 58
Citation count: 397
H-index: 12
I10-index: 15
Year
Topic
Type